NUVB
Nuvation Bio Inc.
Set alert
4.76 USD -0.01 -0.21%
4.60 Day range 4.81
4.05 52-week range 9.54
- YTD
- -46.88%
- 1 year
- -7.57%
- Open
- 4.75
- Prev close
- 4.77
- Mkt cap
- 1.67B
- Vol
- 5.06M
- Avg vol
- 5.35M
- EPS
- -0.44
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 4.60
- High
- 4.81
- Forward P/E
- -317.00
- Beta
- 1.62
- Short ratio
- 11.57
- Inst. own
- 67.84%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 4, 2026
- 50-d avg
- 5.68
- 200-d avg
- 5.41
- 1y target
- 13.00
Financial health
Altman Z-Score
0.52 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
3 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C-1 / 5 overall
- DCF 3
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 1
- P/E 1
- P/B 1
Valuation
P/E -14.9×
FY 2018 5y median -4.3× FY 2025
P/S 48.7×
FY 2018 5y median 0.0× FY 2025
P/B 10.0×
FY 2018 5y median 1.5× FY 2025
P/FCF -17.6×
FY 2018 5y median -5.5× FY 2025
EV/EBITDA -15.4×
FY 2018 5y median -3.9× FY 2025
EV/Sales 46.2×
FY 2018 5y median 0.0× FY 2025
FCF Yield -5.7%
FY 2018 5y median -18.3% FY 2025
Profitability
Gross Margin 86.6%
FY 2018 5y median 0.0% FY 2025
Operating Margin -338.7%
FY 2018 5y median 0.0% FY 2025
Net Margin -325.3%
FY 2018 5y median 0.0% FY 2025
ROE -66.9%
FY 2018 5y median -15.9% FY 2025
ROIC -41.0%
FY 2018 5y median -18.1% FY 2025
ROA -34.4%
FY 2018 5y median -15.5% FY 2025
Growth (YoY)
Revenue 699.0%
FY 2018 FY 2025
Operating Income 64.0%
FY 2018 FY 2025
EPS (diluted) 71.6%
FY 2018 FY 2025
Free Cash Flow -33.1%
FY 2018 FY 2025
Financial Health
Current Ratio 7.0×
FY 2018 5y median 44.1× FY 2025
Quick Ratio 6.8×
FY 2018 5y median 44.1× FY 2025
Debt / Equity 0.0×
FY 2018 5y median 0.0× FY 2025
Net Debt / EBITDA 0.8×
FY 2018 5y median 0.8× FY 2025
Interest Coverage -15.6×
FY 2018 5y median 0.0× FY 2025
Dividends
Dividend Yield 0.0%
FY 2018 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2018 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31